EphA2 inhibits SRA01/04 cells apoptosis by suppressing autophagy via activating PI3K/Akt/mTOR pathway

Jing Han1, Lisong Wang1, Huayi Lv1

  • 1Department of Ophthalmology, Affiliated First Hospital of USTC, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, 230001, Anhui, China.

Insights

EphA2 protein protects lens epithelial cells from hydrogen peroxide damage by inhibiting apoptosis and autophagy. This involves activating the PI3K/Akt/mTOR pathway, crucial for cell survival.

Area of Science:

  • Cell Biology
  • Molecular Biology
  • Ophthalmology

Background:

  • Oxidative stress, particularly from hydrogen peroxide (H2O2), is implicated in lens epithelial cell damage.
  • The role of EphA2 receptor tyrosine kinase in cellular responses to oxidative stress is not fully understood.

Purpose of the Study:

  • To investigate the effect of EphA2 on H2O2-treated lens epithelial cells (SRA01/04).
  • To elucidate the underlying molecular mechanisms, focusing on apoptosis, autophagy, and the PI3K/Akt/mTOR pathway.

Main Methods:

  • Cell viability and apoptosis assessed using MTT assay and flow cytometry.
  • Protein levels related to apoptosis and autophagy analyzed via Western blot.
  • Involvement of signaling pathways confirmed through specific inhibitors (MK-2206, Rapa).

Main Results:

  • EphA2 overexpression increased cell viability and decreased apoptosis in H2O2-treated cells.
  • EphA2 upregulated anti-apoptotic Bcl-2 and downregulated pro-apoptotic Cleaved-caspase-3 and Bax.
  • EphA2 suppressed autophagy and activated the PI3K/Akt/mTOR pathway (p-Akt, p-mTOR).

Conclusions:

  • EphA2 protects lens epithelial cells from H2O2-induced apoptosis by inhibiting autophagy.
  • The protective mechanism involves the activation of the PI3K/Akt/mTOR signaling pathway.

Related Concept Videos

PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
4.2K
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
9.6K
Autophagic Cell Death01:18

Autophagic Cell Death

Christian de Duve discovered “autophagy,” a process in which cellular components are engulfed by membrane-bound organelles called autophagosomes. The autophagosomes then fuse with lysosomes to digest the enclosed contents. Autophagy is generally activated in cells to prevent cell death. However, cell death is triggered when the damage is beyond repair.
Autophagy and Apoptosis
Autophagy can activate apoptosis. In normal conditions, the autophagy activating protein Beclin-1 and...
3.6K
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
7.1K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
4.0K
Role of Ephrin-Eph Signalling in Intestinal Stem Cell Renewal01:22

Role of Ephrin-Eph Signalling in Intestinal Stem Cell Renewal

Erythropoietin-producing hepatocellular carcinoma receptor (Eph) and its ligand, Eph receptor-interacting protein (Ephrin) were first discovered in the human carcinoma cell line, hence the name. Ephrin-Eph interaction guides cells to reach their appropriate location in adult tissues. They also play an essential role in the immune system by helping in immune cell migration, adhesion, and activation. Based on their structure and function, Eph is divided into two classes — EphA and EphB.
2.4K